Artículos de revistas sobre el tema "Philip Johnson Associates"
Crea una cita precisa en los estilos APA, MLA, Chicago, Harvard y otros
Consulte los 43 mejores artículos de revistas para su investigación sobre el tema "Philip Johnson Associates".
Junto a cada fuente en la lista de referencias hay un botón "Agregar a la bibliografía". Pulsa este botón, y generaremos automáticamente la referencia bibliográfica para la obra elegida en el estilo de cita que necesites: APA, MLA, Harvard, Vancouver, Chicago, etc.
También puede descargar el texto completo de la publicación académica en formato pdf y leer en línea su resumen siempre que esté disponible en los metadatos.
Explore artículos de revistas sobre una amplia variedad de disciplinas y organice su bibliografía correctamente.
Chohan, S., A. Kavanaugh, V. Strand, R. C. Chou, A. M. Mendelsohn, S. Rozzo y P. J. Mease. "AB0803 EFFICACY OF TILDRAKIZUMAB IN PsA: DAS28-CRP SCORES THROUGH WEEK 52". Annals of the Rheumatic Diseases 79, Suppl 1 (junio de 2020): 1702–3. http://dx.doi.org/10.1136/annrheumdis-2020-eular.3907.
Texto completoJayne, D., P. Gavin, E. Allman, C. Di Poto, X. Tian, S. Hess, M. Ramaswamy et al. "OP0136 METABOLOMIC SERUM PROFILING IDENTIFIES METABOLITES LINKED TO KIDNEY DAMAGE WHICH ARE MODULATED BY ANIFROLUMAB IN A PHASE 2 TRIAL IN LUPUS NEPHRITIS". Annals of the Rheumatic Diseases 82, Suppl 1 (30 de mayo de 2023): 90.1–90. http://dx.doi.org/10.1136/annrheumdis-2023-eular.1569.
Texto completoPray, C., N. Narula, E. C. Wong, J. K. Marshall, S. Rangarajan, S. Islam, A. Bahonar et al. "A176 ASSOCIATIONS OF ANTIBIOTICS, HORMONAL THERAPIES, ORAL CONTRACEPTIVES, AND LONG-TERM NSAIDS WITH INFLAMMATORY BOWEL DISEASE: RESULTS FROM THE PROSPECTIVE URBAN RURAL EPIDEMIOLOGY (PURE) STUDY". Journal of the Canadian Association of Gastroenterology 6, Supplement_1 (1 de marzo de 2023): 20–22. http://dx.doi.org/10.1093/jcag/gwac036.176.
Texto completoRahman, P., C. T. Ritchlin, P. Helliwell, W. H. Boehncke, P. J. Mease, A. B. Gottlieb, S. Kafka et al. "FRI0359 INTEGRATED SAFETY RESULTS OF TWO PHASE-3 TRIALS OF GUSELKUMAB IN PATIENTS WITH PSORIATIC ARTHRITIS THROUGH THE PLACEBO-CONTROLLED PERIODS". Annals of the Rheumatic Diseases 79, Suppl 1 (junio de 2020): 776–77. http://dx.doi.org/10.1136/annrheumdis-2020-eular.387.
Texto completoRahman, P., P. J. Mease, A. Deodhar, A. Kavanaugh, S. D. Chakravarty, A. Kollmeier, Y. Liu, M. Shawi y C. Han. "OP0025 FACTORS ASSOCIATED WITH FATIGUE AND ITS IMPROVEMENT – A PRINCIPAL COMPONENT ANALYSIS OF PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS FROM GUSELKUMAB PHASE 3 TRIALS". Annals of the Rheumatic Diseases 81, Suppl 1 (23 de mayo de 2022): 18–19. http://dx.doi.org/10.1136/annrheumdis-2022-eular.895.
Texto completoCoates, L. C., C. T. Ritchlin, L. Gossec, P. Helliwell, P. Rahman, E. C. Hsia, A. Kollmeier et al. "POS1024 GUSELKUMAB PROVIDES SUSTAINED DOMAIN-SPECIFIC AND COMPREHENSIVE EFFICACY AS ASSESSED USING COMPOSITE ENDPOINTS IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS". Annals of the Rheumatic Diseases 80, Suppl 1 (19 de mayo de 2021): 781–82. http://dx.doi.org/10.1136/annrheumdis-2021-eular.167.
Texto completoCurtis, J., I. Mcinnes, D. D. Gladman, F. Yang, S. Peterson, P. Agarwal, A. Kollmeier et al. "POS1028 PATIENT CHARACTERISTICS & CLINICAL FEATURES ASSOCIATE WITH HEALTH-RELATED QUALITY OF LIFE IN BIO-NAÏVE PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS THROUGH WEEK 24 OF THE DISCOVER-2 STUDY". Annals of the Rheumatic Diseases 80, Suppl 1 (19 de mayo de 2021): 784–85. http://dx.doi.org/10.1136/annrheumdis-2021-eular.432.
Texto completoCoates, L., J. Ramírez, D. Mcgonagle, S. Aydin, M. Zimmermann, F. Nantel, M. Shawi, E. Rampakakis, P. Nash y P. J. Mease. "POS1540 EARLY SKIN AND EARLY ENTHESITIS RESPONSES IN PSORIATIC ARTHRITIS PATIENTS TREATED WITH GUSELKUMAB ASSOCIATE WITH LONG-TERM RESPONSE: POST HOC ANALYSIS THROUGH 2 YEARS OF A PHASE 3 STUDY". Annals of the Rheumatic Diseases 82, Suppl 1 (30 de mayo de 2023): 1137.1–1137. http://dx.doi.org/10.1136/annrheumdis-2023-eular.2581.
Texto completoMcgonagle, D., I. Mcinnes, A. Deodhar, G. Schett, P. J. Mease, M. Shawi, S. Kafka et al. "AB0801 EFFECTS OF GUSELKUMAB, A MONOCLONAL ANTIBODY THAT SPECIFICALLY BINDS TO THE P19-SUBUNIT OF INTERLEUKIN-23, ON DACTYLITIS AND ENTHESITIS IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS: POOLED RESULTS THROUGH WEEK 24 FROM TWO PHASE 3 STUDIES". Annals of the Rheumatic Diseases 79, Suppl 1 (junio de 2020): 1701.2–1701. http://dx.doi.org/10.1136/annrheumdis-2020-eular.836.
Texto completoCurtis, J., I. McInnes, P. Rahman, D. D. Gladman, F. Yang, S. Peterson, A. Kollmeier et al. "AB0881 Guselkumab Provides Sustained Improvements in Health-Related Quality of Life in Patients With Active Psoriatic Arthritis Through 2 Years of DISCOVER-2". Annals of the Rheumatic Diseases 81, Suppl 1 (23 de mayo de 2022): 1563.2–1564. http://dx.doi.org/10.1136/annrheumdis-2022-eular.733.
Texto completoGossec, L., D. Aletaha, P. Sewerin, A. Zabotti, F. Van den Bosch, M. Efficace, F. Lavie, M. Zimmermann, M. Sharaf y I. Mcinnes. "AB1082 EARLY CLINICAL RESPONSE AS A PREDICTOR OF LONG-TERM HEALTH-RELATED QUALITY OF LIFE IMPROVEMENTS IN PATIENTS WITH PSORIATIC ARTHRITIS AND TNFI-IR RECEIVING GUSELKUMAB (COSMOS)". Annals of the Rheumatic Diseases 82, Suppl 1 (30 de mayo de 2023): 1761.1–1761. http://dx.doi.org/10.1136/annrheumdis-2023-eular.359.
Texto completoSewerin, P., L. Dötsch, D. Truhm, D. Abrar y S. Nebelung. "THU0062 FUNCTIONAL MR IMAGING OF HUMAN MENISCUS IS ASSOCIATED WITH HISTOLOGICAL DEGENERATION". Annals of the Rheumatic Diseases 79, Suppl 1 (junio de 2020): 243. http://dx.doi.org/10.1136/annrheumdis-2020-eular.6403.
Texto completoCoates, L., I. Mcinnes, S. Aydin, M. Kishimoto, P. J. Mease, M. Shawi, M. Zimmermann, E. Rampakakis, F. Lavie y D. Mcgonagle. "POS0027 INDIVIDUAL ENTHESEAL POINTS HAVE DIFFERENTIAL FREQUENCY OF INVOLVEMENT AND IMPACT ON PATIENT REPORTED OUTCOMES IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS: POOLED ANALYSIS OF TWO PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDIES". Annals of the Rheumatic Diseases 82, Suppl 1 (30 de mayo de 2023): 220–21. http://dx.doi.org/10.1136/annrheumdis-2023-eular.122.
Texto completoCurtis, J., I. Mcinnes, S. Peterson, P. Agarwal, F. Yang, A. Kollmeier, E. C. Hsia et al. "POS1026 GUSELKUMAB PROVIDES SUSTAINED IMPROVEMENTS IN WORK PRODUCTIVITY AND NON-WORK ACTIVITY IN PATIENTS WITH PSORIATIC ARTHRITIS: RESULTS THROUGH 1 YEAR OF A PHASE 3 TRIAL". Annals of the Rheumatic Diseases 80, Suppl 1 (19 de mayo de 2021): 782.2–783. http://dx.doi.org/10.1136/annrheumdis-2021-eular.244.
Texto completoNash, P., I. Mcinnes, C. T. Ritchlin, L. S. Tam, E. Soriano, M. Starr, E. Rampakakis et al. "AB1095 IMPACT OF PSORIATIC ARTHRITIS MANIFESTATIONS ON PERCEPTION OF PAIN IMPROVEMENT: POOLED ANALYSIS OF TWO PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDIES WITH GUSELKUMAB". Annals of the Rheumatic Diseases 82, Suppl 1 (30 de mayo de 2023): 1771–72. http://dx.doi.org/10.1136/annrheumdis-2023-eular.555.
Texto completoBaraliakos, X., D. D. Gladman, S. D. Chakravarty, C. Gong, M. Shawi, E. Rampakakis, M. Kishimoto, E. Soriano y P. J. Mease. "POS0023 PERFORMANCE OF BASDAI VS. ASDAS IN EVALUATING AXIAL INVOLVEMENT IN PATIENTS WITH PSA TREATED WITH GUSELKUMAB: POOLED ANALYSIS OF TWO PHASE 3 STUDIES". Annals of the Rheumatic Diseases 82, Suppl 1 (30 de mayo de 2023): 217.2–218. http://dx.doi.org/10.1136/annrheumdis-2023-eular.2761.
Texto completoGladman, D. D., M. Starr, R. Ranza, A. M. Bravo Perdomo, M. Strauss, M. Shawi, C. Han, E. Rampakakis, A. Andrew Östör y P. J. Mease. "AB1087 LONG-TERM EFFICACY OF GUSELKUMAB IN FATIGUE AND IDENTIFICATION OF EARLY TREATMENT TARGETS: POST HOC ANALYSIS THROUGH 2 YEARS OF A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY CONDUCTED IN BIOLOGIC-NAÏVE PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS". Annals of the Rheumatic Diseases 82, Suppl 1 (30 de mayo de 2023): 1765.1–1765. http://dx.doi.org/10.1136/annrheumdis-2023-eular.1918.
Texto completoMease, P. J., P. Foley, K. Reich, J. Bagel, M. Lebwohl, Y. W. Yang, M. Shawi et al. "POS1031 LOW INCIDENCE OF GASTROINTESTINAL-RELATED AND OVERALL SERIOUS ADVERSE EVENTS AMONG GUSELKUMAB-TREATED PATIENTS: POOLED ANALYSES OF VOYAGE 1 & 2 AND DISCOVER 1 & 2 THROUGH 1-YEAR". Annals of the Rheumatic Diseases 80, Suppl 1 (19 de mayo de 2021): 787–88. http://dx.doi.org/10.1136/annrheumdis-2021-eular.558.
Texto completoOrbai, A. M., L. C. Coates, A. Deodhar, P. Helliwell, C. T. Ritchlin, A. Kollmeier, E. C. Hsia et al. "POS1029 GUSELKUMAB-TREATED PATIENTS WITH PSORIATIC ARTHRITIS ACHIEVED CLINICALLY MEANINGFUL IMPROVEMENTS IN GENERAL HEALTH OUTCOMES MEASURED WITH PROMIS-29 THROUGH 52 WEEKS: RESULTS FROM THE PHASE 3 DISCOVER-1 TRIAL". Annals of the Rheumatic Diseases 80, Suppl 1 (19 de mayo de 2021): 785–86. http://dx.doi.org/10.1136/annrheumdis-2021-eular.471.
Texto completoCurtis, J., I. Mcinnes, P. Rahman, D. D. Gladman, F. Yang, S. Peterson, A. Kollmeier et al. "AB0888 Guselkumab Provides Sustained Improvements in Work Productivity and Daily Activity in Patients With Active Psoriatic Arthritis Through 2 Years of DISCOVER-2". Annals of the Rheumatic Diseases 81, Suppl 1 (23 de mayo de 2022): 1568–69. http://dx.doi.org/10.1136/annrheumdis-2022-eular.1366.
Texto completoCoates, L., P. Rahman, P. J. Mease, M. Shawi, E. Rampakakis, A. Kollmeier, X. L. Xu, S. D. Chakravarty, I. Mcinnes y L. S. Tam. "POS1067 DOMAINS CONTRIBUTING TO MINIMAL DISEASE ACTIVITY ACHIEVEMENT IN PATIENTS WITH PSORIATIC ARTHRITIS RECEIVING GUSELKUMAB". Annals of the Rheumatic Diseases 81, Suppl 1 (23 de mayo de 2022): 856–57. http://dx.doi.org/10.1136/annrheumdis-2022-eular.893.
Texto completoRitchlin, C. T., P. J. Mease, W. H. Boehncke, J. Tesser, S. D. Chakravarty, E. Rampakakis, M. Shawi et al. "AB1104 STRINGENT DISEASE ACTIVITY CONTROL AT 2 YEARS ACROSS PSORIATIC ARTHRITIS DOMAINS IRRESPECTIVE OF BASELINE CHARACTERISTICS IN PATIENTS TREATED WITH GUSELKUMAB: POST-HOC ANALYSIS OF A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY". Annals of the Rheumatic Diseases 82, Suppl 1 (30 de mayo de 2023): 1779–80. http://dx.doi.org/10.1136/annrheumdis-2023-eular.3238.
Texto completoTillett, W., L. Coates, M. Vis, E. Soriano, J. F. Merola, M. Zimmermann, M. Shawi, M. Sharaf, P. Nash y P. Helliwell. "POS1535 EARLY IMPROVEMENT IN 3VAS/4VAS PREDICTS REDUCED RATES OF RADIOGRAPHIC CHANGE IN BIO-NAIVE ACTIVE PSORIATIC ARTHRITIS PATIENTS RECEIVING GUSELKUMAB TREATMENT". Annals of the Rheumatic Diseases 82, Suppl 1 (30 de mayo de 2023): 1131–32. http://dx.doi.org/10.1136/annrheumdis-2023-eular.1690.
Texto completoDu, Wenxuan, Adrian Johnston, Praful Nair, Jingyi Zhu, Khin Sandar Win, Bryan Zhou, Jude Phillip, Pei-Hsun Wu y Denis Wirtz. "Abstract 5949: Modulate TAM infiltration at cancer-immune interface by targeting at monocyte migration". Cancer Research 83, n.º 7_Supplement (4 de abril de 2023): 5949. http://dx.doi.org/10.1158/1538-7445.am2023-5949.
Texto completoLippert, Anna L., Katherine A. Johnson, Cheri A. Pasch, Sean G. Kraus, Philip B. Emmerich, Linda Clipson, Kristina A. Matkowskyj, Wei Zhang y Dustin A. Deming. "Abstract 3198: Validation and analysis of cancer associated fibroblast subtype markers in metastatic colorectal cancer". Cancer Research 82, n.º 12_Supplement (15 de junio de 2022): 3198. http://dx.doi.org/10.1158/1538-7445.am2022-3198.
Texto completoGudikote, Jayanthi, Tina Cascone, Alissa Poteete, Piyada Sitthideatphaiboon, Sonia Patel, Yan Yang, Fahao Zhang et al. "Abstract 5733: Targeting nonsense-mediated decay restores p53 function in HPV-associated head and neck cancers". Cancer Research 82, n.º 12_Supplement (15 de junio de 2022): 5733. http://dx.doi.org/10.1158/1538-7445.am2022-5733.
Texto completoTaylor, P. C., K. De Vlam, A. G. Bushmakin, L. Fallon, J. F. Merola, J. C. Cappelleri, M. A. Hsu y P. J. Mease. "AB0838 IDENTIFYING MEDIATORS OF PAIN REDUCTION IN PATIENTS WITH PSORIATIC ARTHRITIS TREATED WITH TOFACITINIB: ROLE OF INFLAMMATION ASSOCIATED WITH PERIPHERAL ARTHRITIS, ENTHESITIS AND SKIN DISEASE". Annals of the Rheumatic Diseases 79, Suppl 1 (junio de 2020): 1724–25. http://dx.doi.org/10.1136/annrheumdis-2020-eular.1052.
Texto completoJohnson, Katherine Anne, Anna L. Lippert, Sean G. Kraus, Grace E. McGrath, Philip B. Emmerich, Cheri A. Pasch, Linda Clipson, Kristina A. Matkowskyj, Wei Zhang y Dustin A. Deming. "Abstract 3533: Effects of tyrosine kinase inhibitors imatinib, dasatinib, and nilotinib on cancer-associated fibroblast phenotypes in colorectal cancer". Cancer Research 82, n.º 12_Supplement (15 de junio de 2022): 3533. http://dx.doi.org/10.1158/1538-7445.am2022-3533.
Texto completoDale, David, Audrey Anna Bolyard, Emily Dick, Merideth L. Kelley, Vahagn Makaryan, Ramsey Johnson, Lu Gan y Sudha Parasuraman. "X4P-001: A Novel Molecularly-Targeted Oral Therapy for Whim Syndrome". Blood 130, Suppl_1 (7 de diciembre de 2017): 995. http://dx.doi.org/10.1182/blood.v130.suppl_1.995.995.
Texto completoChaudhuri, Somak, Dustin A. Deming, Cheri A. Pasch, Katherine A. Johnson, Chelsie K. Sievers y Philip B. Emmerich. "Abstract 1581: Colony-stimulating factor-1 receptor as a potential therapeutic target in pancreatic ductal adenocarcinoma". Cancer Research 84, n.º 6_Supplement (22 de marzo de 2024): 1581. http://dx.doi.org/10.1158/1538-7445.am2024-1581.
Texto completoBrooks, J., A. Montgomery, N. Dalbeth, M. Sapsford, A. Cooper, R. Ngan Kee, V. Quincey et al. "OP0079 OMICRON VARIANT INFECTION IN INFLAMMATORY RHEUMATOLOGICAL CONDITIONS - OUTCOMES FROM A COVID-19 NAIVE POPULATION IN AOTEAROA NEW ZEALAND". Annals of the Rheumatic Diseases 82, Suppl 1 (30 de mayo de 2023): 54–55. http://dx.doi.org/10.1136/annrheumdis-2023-eular.1749.
Texto completoHilliard, Tyvette, Phillip Petrasko, Yueying Liu, Jing Yang, Marwa Asem, Jeff Johnson, Gifty Marfowaa et al. "Abstract 2189: The role of generational obesity on the ovarian metastatic niche". Cancer Research 82, n.º 12_Supplement (15 de junio de 2022): 2189. http://dx.doi.org/10.1158/1538-7445.am2022-2189.
Texto completoGossec, L., P. J. Mease, A. B. Gottlieb, A. Ogdie, D. Assudani, J. Coarse, B. Ink y L. C. Coates. "AB0778 ASSOCIATION BETWEEN PATIENT-REPORTED OUTCOMES AND DISEASE ACTIVITY IN BIMEKIZUMAB-TREATED PATIENTS WITH PSORIATIC ARTHRITIS". Annals of the Rheumatic Diseases 79, Suppl 1 (junio de 2020): 1687.1–1687. http://dx.doi.org/10.1136/annrheumdis-2020-eular.4204.
Texto completoWahyuni, Anna Tri, Masfuri Masfuri y Liya Arista. "FAKTOR-FAKTOR YANG MEMPENGARUHI MORTALITAS PADA PASIEN DENGAN FRAKTUR COSTA: Literature Review". Jurnal Keperawatan Widya Gantari Indonesia 6, n.º 2 (20 de julio de 2022): 157. http://dx.doi.org/10.52020/jkwgi.v6i2.4151.
Texto completoMI KANG, YU, GIORGIO E. M. MELLONI, AVIVIT CAHN, ITAMAR RAZ, FILIPE MOURA, DEEPAK L. BHATT, SILVIO E. INZUCCHI et al. "1896-LB: Clinical Features and C-Peptide Levels Associated with Diabetic Ketoacidosis in Patients with Type 2 Diabetes on Dapagliflozin vs. Placebo—Insights from DECLARE-TIMI 58". Diabetes 73, Supplement_1 (14 de junio de 2024). http://dx.doi.org/10.2337/db24-1896-lb.
Texto completoMI KANG, YU, GIORGIO E. M. MELLONI, AVIVIT CAHN, ITAMAR RAZ, FILIPE MOURA, DEEPAK L. BHATT, SILVIO E. INZUCCHI et al. "1895-LB: Fasting C-Peptide and Type 1 Diabetes Polygenic Score Predict Diabetic Ketoacidosis in People with Type 2 Diabetes in DECLARE-TIMI 58". Diabetes 73, Supplement_1 (14 de junio de 2024). http://dx.doi.org/10.2337/db24-1895-lb.
Texto completoGao, Xiang. "A ‘Uniform’ for All States?" M/C Journal 26, n.º 1 (15 de marzo de 2023). http://dx.doi.org/10.5204/mcj.2962.
Texto completoGoggin, Gerard y Christopher Newell. "Fame and Disability". M/C Journal 7, n.º 5 (1 de noviembre de 2004). http://dx.doi.org/10.5204/mcj.2404.
Texto completoFelton, Emma. "Brisbane: Urban Construction, Suburban Dreaming". M/C Journal 14, n.º 4 (22 de agosto de 2011). http://dx.doi.org/10.5204/mcj.376.
Texto completoHarrison, Karey. "Building Resilient Communities". M/C Journal 16, n.º 5 (24 de agosto de 2013). http://dx.doi.org/10.5204/mcj.716.
Texto completoLyons, Craig, Alexandra Crosby y H. Morgan-Harris. "Going on a Field Trip: Critical Geographical Walking Tours and Tactical Media as Urban Praxis in Sydney, Australia". M/C Journal 21, n.º 4 (15 de octubre de 2018). http://dx.doi.org/10.5204/mcj.1446.
Texto completoRaffa, Taylor, Parker Chang, Babak Sarani y Susan Kartiko. "Surgical Stabilization of Rib Fractures: A Review of the Indications, Technique, and Outcomes". Medical Research Archives 11, n.º 11 (2023). http://dx.doi.org/10.18103/mra.v11i11.4694.
Texto completoBrien, Donna Lee. "From Waste to Superbrand: The Uneasy Relationship between Vegemite and Its Origins". M/C Journal 13, n.º 4 (18 de agosto de 2010). http://dx.doi.org/10.5204/mcj.245.
Texto completo